Business Description
Transcenta Holding Limited is a biopharmaceutical company based in Suzhou, China, focused on discovering and developing new medicines to treat cancers and immune-related diseases in both China and the United States. The company is building a broad portfolio of antibody-based treatments targeting difficult-to-treat conditions such as gastric cancer, breast cancer, osteoporosis, and kidney disease. Transcenta works alongside research partners including Dana-Farber Cancer Institute and Johns Hopkins University to advance its drug pipeline. Founded in 2010, the company has grown from its origins as MabSpace International Limited into a clinical-stage organization with multiple drug candidates in active development.
